vs

Side-by-side financial comparison of ASCENT INDUSTRIES CO. (ACNT) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.

ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $11.9M, roughly 1.5× ASCENT INDUSTRIES CO.). ROCKWELL MEDICAL, INC. runs the higher net margin — -3.0% vs -8.8%, a 5.7% gap on every dollar of revenue. On growth, ASCENT INDUSTRIES CO. posted the faster year-over-year revenue change (13.3% vs -25.6%). ROCKWELL MEDICAL, INC. produced more free cash flow last quarter ($2.2M vs $-196.0K). Over the past eight quarters, ROCKWELL MEDICAL, INC.'s revenue compounded faster (-10.1% CAGR vs -34.9%).

Ascent Capital Group, Inc. was a publicly traded holding company whose primary subsidiary was Monitronics. Ascent Media was a wholly owned subsidiary of the Discovery Holding Company (DHC). DHC spun off Ascent Media as an independent, public company on September 17, 2008.

Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).

ACNT vs RMTI — Head-to-Head

Bigger by revenue
RMTI
RMTI
1.5× larger
RMTI
$18.3M
$11.9M
ACNT
Growing faster (revenue YoY)
ACNT
ACNT
+39.0% gap
ACNT
13.3%
-25.6%
RMTI
Higher net margin
RMTI
RMTI
5.7% more per $
RMTI
-3.0%
-8.8%
ACNT
More free cash flow
RMTI
RMTI
$2.4M more FCF
RMTI
$2.2M
$-196.0K
ACNT
Faster 2-yr revenue CAGR
RMTI
RMTI
Annualised
RMTI
-10.1%
-34.9%
ACNT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACNT
ACNT
RMTI
RMTI
Revenue
$11.9M
$18.3M
Net Profit
$-1.0M
$-554.0K
Gross Margin
14.6%
21.1%
Operating Margin
-21.0%
-2.2%
Net Margin
-8.8%
-3.0%
Revenue YoY
13.3%
-25.6%
Net Profit YoY
-1.2%
26.7%
EPS (diluted)
$-0.11
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACNT
ACNT
RMTI
RMTI
Q4 25
$11.9M
$18.3M
Q3 25
$19.7M
$15.9M
Q2 25
$18.7M
$16.1M
Q1 25
$24.7M
$18.9M
Q4 24
$10.5M
$24.7M
Q3 24
$20.9M
$28.3M
Q2 24
$21.5M
$25.8M
Q1 24
$28.0M
$22.7M
Net Profit
ACNT
ACNT
RMTI
RMTI
Q4 25
$-1.0M
$-554.0K
Q3 25
$-2.1M
$-1.8M
Q2 25
$6.3M
$-1.5M
Q1 25
$-2.3M
$-1.5M
Q4 24
$-1.0M
$-756.0K
Q3 24
$-6.2M
$1.7M
Q2 24
$-926.0K
$343.0K
Q1 24
$-5.5M
$-1.7M
Gross Margin
ACNT
ACNT
RMTI
RMTI
Q4 25
14.6%
21.1%
Q3 25
29.7%
14.3%
Q2 25
26.1%
15.6%
Q1 25
19.3%
16.1%
Q4 24
24.3%
14.7%
Q3 24
14.4%
22.0%
Q2 24
13.1%
17.6%
Q1 24
8.3%
13.5%
Operating Margin
ACNT
ACNT
RMTI
RMTI
Q4 25
-21.0%
-2.2%
Q3 25
-4.1%
-9.9%
Q2 25
-14.4%
-8.4%
Q1 25
-4.2%
-7.2%
Q4 24
-25.4%
-2.1%
Q3 24
-9.4%
6.8%
Q2 24
-8.6%
2.0%
Q1 24
-15.5%
-5.8%
Net Margin
ACNT
ACNT
RMTI
RMTI
Q4 25
-8.8%
-3.0%
Q3 25
-10.6%
-11.0%
Q2 25
33.7%
-9.3%
Q1 25
-9.3%
-8.0%
Q4 24
-9.8%
-3.1%
Q3 24
-29.5%
5.9%
Q2 24
-4.3%
1.3%
Q1 24
-19.7%
-7.6%
EPS (diluted)
ACNT
ACNT
RMTI
RMTI
Q4 25
$-0.11
$-0.01
Q3 25
$-0.22
$-0.05
Q2 25
$0.65
$-0.05
Q1 25
$-0.23
$-0.04
Q4 24
$-0.11
$-0.02
Q3 24
$-0.61
$0.04
Q2 24
$-0.09
$0.01
Q1 24
$-0.54
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACNT
ACNT
RMTI
RMTI
Cash + ST InvestmentsLiquidity on hand
$57.6M
$10.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$87.0M
$37.0M
Total Assets
$111.9M
$57.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACNT
ACNT
RMTI
RMTI
Q4 25
$57.6M
$10.7M
Q3 25
$58.0M
$13.6M
Q2 25
$60.5M
$12.5M
Q1 25
$14.3M
$11.4M
Q4 24
$16.1M
$15.7M
Q3 24
$8.5M
$12.3M
Q2 24
$3.6M
$11.9M
Q1 24
$1.3M
$6.6M
Total Debt
ACNT
ACNT
RMTI
RMTI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ACNT
ACNT
RMTI
RMTI
Q4 25
$87.0M
$37.0M
Q3 25
$87.1M
$37.0M
Q2 25
$89.7M
$30.4M
Q1 25
$91.2M
$31.5M
Q4 24
$93.5M
$32.6M
Q3 24
$94.7M
$29.1M
Q2 24
$101.0M
$23.5M
Q1 24
$102.0M
$20.6M
Total Assets
ACNT
ACNT
RMTI
RMTI
Q4 25
$111.9M
$57.1M
Q3 25
$119.9M
$57.5M
Q2 25
$122.6M
$52.6M
Q1 25
$152.5M
$54.0M
Q4 24
$147.3M
$59.2M
Q3 24
$148.6M
$57.1M
Q2 24
$158.2M
$53.0M
Q1 24
$161.0M
$50.7M
Debt / Equity
ACNT
ACNT
RMTI
RMTI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACNT
ACNT
RMTI
RMTI
Operating Cash FlowLast quarter
$266.0K
$2.3M
Free Cash FlowOCF − Capex
$-196.0K
$2.2M
FCF MarginFCF / Revenue
-1.7%
12.0%
Capex IntensityCapex / Revenue
3.9%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-2.1M
$-1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACNT
ACNT
RMTI
RMTI
Q4 25
$266.0K
$2.3M
Q3 25
$1.3M
$-1.3M
Q2 25
$-1.4M
$1.8M
Q1 25
$-700.0K
$-3.5M
Q4 24
$8.8M
$865.0K
Q3 24
$3.4M
$4.3M
Q2 24
$2.2M
$1.4M
Q1 24
$263.0K
$-2.4M
Free Cash Flow
ACNT
ACNT
RMTI
RMTI
Q4 25
$-196.0K
$2.2M
Q3 25
$695.0K
$-1.5M
Q2 25
$-1.5M
$1.7M
Q1 25
$-1.0M
$-3.5M
Q4 24
$8.4M
$470.0K
Q3 24
$3.1M
$4.1M
Q2 24
$1.9M
$1.2M
Q1 24
$25.0K
$-2.5M
FCF Margin
ACNT
ACNT
RMTI
RMTI
Q4 25
-1.7%
12.0%
Q3 25
3.5%
-9.6%
Q2 25
-8.3%
10.5%
Q1 25
-4.1%
-18.8%
Q4 24
80.6%
1.9%
Q3 24
15.1%
14.4%
Q2 24
9.1%
4.5%
Q1 24
0.1%
-11.1%
Capex Intensity
ACNT
ACNT
RMTI
RMTI
Q4 25
3.9%
0.5%
Q3 25
3.1%
1.4%
Q2 25
0.8%
1.0%
Q1 25
1.3%
0.3%
Q4 24
3.7%
1.6%
Q3 24
1.3%
0.7%
Q2 24
1.0%
1.1%
Q1 24
0.9%
0.6%
Cash Conversion
ACNT
ACNT
RMTI
RMTI
Q4 25
Q3 25
Q2 25
-0.22×
Q1 25
Q4 24
Q3 24
2.57×
Q2 24
4.20×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACNT
ACNT

Other$6.1M52%
Transferred At Point In Time$5.7M48%

RMTI
RMTI

US$15.9M87%
Non Us$2.4M13%

Related Comparisons